Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 (Q35542572)
Jump to navigation
Jump to search
scientific article published on 27 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 |
scientific article published on 27 April 2015 |
Statements
1 reference
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 (English)
1 reference
Jennifer M Atkinson
1 reference
Kenneth B Rank
1 reference
Yi Zeng
1 reference
Andrew Capen
1 reference
Vipin Yadav
1 reference
Jason R Manro
1 reference
Thomas A Engler
1 reference
Marcio Chedid
1 reference
27 April 2015
1 reference
1 reference
10
1 reference
4
1 reference
e0125028
1 reference
27 April 2015
1 reference
Identifiers
1 reference
1 reference
1 reference